Andrews R Fu B Toomey CE Breiter JC Lachica J Tian R Beckwith JS Needham L Chant GJ Loiseau C Deconfin A Baspin K Magill PJ Jaunmuktane Z Freeman OJ Taylor BJ Hardy J Lashley T Ryten M Vendruscolo M Wood NW Weiss LE Gandhi S Lee SF Large-scale visualisation of α-synuclein oligomers in Parkinson's disease brain tissue
van Rheede JJ Feldmann LK Busch JL Fleming JE Mathiopoulou V Denison T Sharott A Kühn AA Diurnal modulation of subthalamic beta oscillatory power in Parkinson’s disease patients during deep brain stimulation View published paper
Nandi T Puonti O Clarke WT Nettekoven CR Barron HC Kolasinski J Hanayik T Hinson EL Berrington A Bachtiar V Johnstone A Winkler AM Thielscher A Johansen-Berg H Stagg CJ tDCS induced GABA change is associated with the simulated electric field in M1, an effect mediated by grey matter volume in the MRS voxel View published paper
Nettekoven CR Mitchell L Clarke WT Emir UE Campbell J Johansen-Berg H Jenkinson N Stagg CJ Cerebellar GABA change during visuomotor adaptation relates to adaptation performance and cerebellar network connectivity: A Magnetic Resonance Spectroscopic Imaging study View published paper
Duchet B Ghezzi F Weerasinghe G Tinkhauser G Kühn AA Brown P Bick C Bogacz R Average beta burst duration profiles provide a signature of dynamical changes between the ON and OFF medication states in Parkinson’s disease View published paper
